Lenti-HPV-07

· Theravectys S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenti-HPV-07, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer [Phase 1, Phase 2]